Series A startup

Who invested in Cell Matters

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$876Kraised across 1 round since 2018, from 1 source

Latest round
Series A, $876KJan 2018
Investors
1
See who backed them

The rounds

  1. Jan 2018
    Series A$876K

    Source recorded

Founders and team

From Cell Matters's own website: 5 on the team.

  • Adam FoxChief Quality and Regulatory Affairs Officer
  • Hiren ModyChief Financial Officer
  • Matthew PlaudChief Operations Officer – IntegriCell
  • Michael DybiczSVP & Chief Product Development Officer
  • Robin GrimwoodChief Commercial Officer

Everyone who backed them

InventureVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cell Matters

Who invested in Cell Matters?

Cell Matters's investors include Inventure.

How much has Cell Matters raised?

Cell Matters has raised $876K across 1 round since 2018.

When did Cell Matters last raise?

Cell Matters's most recent round was a Series A of $876K in Jan 2018.

What was Cell Matters's biggest round?

Its most recent round, $876K in Jan 2018, is also its largest on record.

Who backed Cell Matters first?

Cell Matters's first round on record, in Jan 2018, was backed by Inventure.

What stage is Cell Matters at?

Cell Matters's latest named round is a Series A, in Jan 2018.

Companies like Cell Matters

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.